Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06891781Not ApplicableNot Yet Recruiting

Investigating Adaptive Deep Brain Stimulation in Parkinson's Disease Management

Role: lead

NCT05262348Not ApplicableWithdrawn

An Open-label Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Deep Brain Stimulation

Role: lead

NCT04681534Not ApplicableRecruiting

Safety and Efficacy of Adaptive Deep Brain Stimulation

Role: lead

NCT03422757Not ApplicableTerminated

Safety and Efficacy of Adaptive DBS Vs Conventional DBS in Patients With Parkinson's Disease

Role: lead

All 4 trials loaded